The FDA has approved both Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) for the treatment of the fatal lung disease Idiopathic Pulmonary Fibrosis (IPF). These new drugs are the first treatments for IPF available in the US. Esbriet previously became the first marketed drug for IPF globally when it was approved in Europe in […]
Archief voor de categorie ‘Overig’
Patiënten met chronische hepatitis C in een verder gevorderd stadium krijgen vanaf 1 november het medicijn sofosbuvir (Sovaldi) voorlopig vergoed uit het basispakket. Minister Edith Schippers (Volksgezondheid) heeft dat besloten na onderhandelingen over de prijs met de fabrikanten van het middel.
Bron: Skipr Meer lezen »
For your content marketing projects to get off the ground, you need to assemble the right team, teach them the right way to do it, and get them motivated for action. It can be daunting to get buy-in from executive staff and team members who may not be well versed in content marketing. Don’t call […]
FDA has approved two new HIV-1 cocktail drugs: elvitegravir (Vitekta, Gilead), an integrase inhibitor and cobicistat (Tybost, Gilead), a protease-inhibitor booster. According to Medscape, elvitegravir is approved in patients with HIV-1 who have previously received antiretroviral treatment. It should be used in combination with an HIV protease inhibitor coadministered with ritonavir and another antiretroviral.
Bron: ModernMedicine: Pharmacy Meer lezen »
NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered and influence decision-making. Getting the most from medicines is becoming increasingly important in the UK as more people are using more medicines NICE says, and as the population ages more people are living with long-term […]
Bron: InPharm.com Meer lezen »
AstraZeneca has launched a photo-sharing campaign on Twitter, Instagram and other social media sites to get women talking about their metastatic breast cancer (MBC). It’s an idea born from patients’ feedback; women say they want to tell their stories and hear from fellow patients, the company says.
Bron: FiercePharma Meer lezen »
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead’s other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Bron: News-Medical.Net Meer lezen »
Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug Administration which can speed its approval process by up to four months. The firm submitted an early application for its drug in August that is used to treat postmenopausal women with advanced breast cancer, in […]
Amgen is on track to launch a biosimilar competitor to AbbVie’s Humira – the biggest-selling pharmaceutical product in the world – after positive data in a phase III trial. The biotech major said that in the first of two late-stage studies, its ABP 501 biosimilar was equivalent to Humira (adalimumab) in terms of its efficacy and […]
Bron: PMLiVE Meer lezen »
New research finds that children who are hospitalized get discharged sooner and come back less often when hospitals take extra efforts to control treatment that uses antibiotics. Some hospitals and other medical facilities have embraced “stewardship programs” designed to make it harder for physicians to prescribe antibiotic medications without a good reason.
Bron: Drugs.com: Drug Information Online Meer lezen »